Dissociation of affinity and efficacy in KOR-3 chimeras

FEBS Letters

Volumn 395, Issue 2-3, 1996, Pages 207-210

  Pan, Ying Xing ^a   Xu, Jin ^a   Ryan Moro, Jennifer ^a   Mathis, John ^a   Hom, Judy S H ^a   Jianfeng, Mei ^a   Pasternak, Gavril W ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

KOR 3; Nociceptin; OLR1; Opioid receptor; Orphanin FQ

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; ADENYLATE CYCLASE; CYCLIC AMP; DIPRENORPHINE; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; MORPHINE SULFATE; NALOXONE BENZOYLHYDRAZONE; OPIATE RECEPTOR;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CHIMERA; CHO CELL; CONTROLLED STUDY; EXON; GENE CONSTRUCT; GENE EXPRESSION; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY;

ANIMALIA;

EID: 0030597209     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-5793(96)01023-X     Document Type: Article

References (25)

1. [1] Reinscheid, R.K., Nothacker, H.P., Bourson, A., Ardati, A., Henningsen, R.A., Bunzow, J.R., Grandy, D.K., Langen, H., Monsma, F.J. and Civelli, O. (1995) Science 270, 792-794.
2. [2] Meunier, J.C., Mollereau, C., Toll, L., Suaudeau, C., Moisand, C., Alvinerie, P., Butour, J.L., Guillemot, J.C., Ferrara, P., Monsarrat, B., Mazargull, H., Vassart, G., Parmentier, M. and Costentin, J. (1995) Nature 377, 532-535.
3. [3] Chen, Y., Fan, Y., Liu, J., Mestek, A., Tian, M., Kozak, C.A. and Yu, L. (1994) FEBS Lett. 347, 279-283.
4. [4] Keith, D., Jr., Maung, T., Anton, B. and Evans, C. (1994) Regul. Pept. 54, 143-144.
5. [5] Uhl, G.R., Childers, S. and Pasternak, G.W. (1994) Trends Neurosci. 17, 89-93.
6. [6] Wick, M.J., Minnerath, S.R., Lin, X., Elde, R., Law, P.-Y. and Loh, H.H. (1994) Mol. Brain Res. 27, 37-44.
7. [7] Wang, J.B., Johnson, P.S., Imai, Y., Persico, A.M., Ozenberger, B.A., Eppler, C.M. and Uhl, G.R. (1994) FEBS Lett. 348, 75-79.
8. [8] Mollereau, C., Parmentier, M., Mailleux, P., Butour, J.L., Moisand, C., Chalon, P., Caput, D., Vassart, G. and Meunier, J.C. (1994) FEBS Lett. 341, 33-38.
9. [9] Lachowicz, J.E., Shen, Y., Monsma, F.J., Jr. and Sibley, D.R. (1995) J. Neurochem. 64, 34-40.
10. [10] Bunzow, J.R., Saez, C., Mortrud, M., Bouvier, C., Williams, J.T., Low, M. and Grandy, D.K. (1994) FEBS Lett. 347, 284-288.
11. [11] Fukuda, K., Kato, S., Mori, K., Nishi, M., Takeshima, H., Iwabe, N., Miyata, T., Houtani, T. and Siguimoti, T. (1994) FEBS Lett. 343, 42-46.
12. [12] Pan, Y.X., Cheng, J., Xu, J. and Pasternak, G.W. (1994) Regul. Pept. 54, 217-218.
13. [13] Pan, Y.-X., Cheng, J., Xu, J., Rossi, G.C., Jacobson, E., Ryan-Moro, J., Brooks, A.I., Dean, G.E., Standifer, K.M. and Pasternak, G.W. (1995) Mol. Pharmacol. 47, 1180-1188.
14. [14] Pan, Y.X., Xu, J. and Pasternak, G.W. (1996) Gene 171, 255-260.
15. [15] Brooks, A.I., Standifer, K.M., Rossi, G.C., Mathis, J.P. and Pasternak, G.W. (1996) Synapse 22, 247-252.
16. [16] Luke, M.C., Hahn, E.F., Price, M. and Pasternak, G.W. (1988) Life Sci. 43, 1249-1256.
17. [17] Rossi, G.C., Pan, Y.-X., Brown, G.P. and Pasternak, G.W. (1995) FEBS Lett. 369, 192-196.
18. [18] Mathis, J.P., Ryan-Moro, J., Chang, A., Hom, J.S.H., Scheinberg, D. and Pasternak, G.W. (1996) submitted.
19. [19] Cheng, Y.-C. and Prusoff, W.H. (1973) Biochem. Pharmacol. 22, 3099-3108.
20. [20] Chou, T.-C. (1974) Mol. Pharmacol. 10, 235-247.
21. [21] Standifer, K.M., Cheng, J., Brooks, A.I., Honrado, C.P., Su, W., Visconti, L.M., Biedler, J.L. and Pasternak, G.W. (1994) J. Pharmacol. Exp. Ther. 270, 1246-1255.
22. [22] Cheng, J., Standifer, K.M., Tublin, P.R., Su, W. and Pasternak, G.W. (1995) J. Neurochem. 65, 170-175.
23. [23] Rossi, G., Leventhal, L., Boland, E. and Pasternak, G.W. (1996) submitted.
24. [24] Rossi, G.C., Leventhal, L. and Pasternak, G.W. (1996) Eur. J. Pharmacol., in press,
25. [25] Gistrak, M.A., Paul, D., Hahn, E.F. and Pasternak, G.W. (1990) J. Pharmacol. Exp. Ther. 251, 469-476.